The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, November 2004

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 13 patents

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 13 patents that reference this research output.

Compositions and methods for modified b cells expressing reassigned biological agents

Grant US-11993646-B2

United States of America

28 May 2024

Self-antigen specific T-cells as vaccines for augmenting engraftment and stability of…

Grant US-11696943-B2

United States of America

11 Jul 2023

Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous…

Grant US-11180729-B2

United States of America

23 Nov 2021

Compositions and methods for modified B cells expressing reassigned biological agents

Grant US-10745468-B2

United States of America

18 Aug 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 9 additional patents.